We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.75 | -7.86516853933 | 22.25 | 22.84 | 18.06 | 322132 | 20.11753186 | CS |
4 | -3.07 | -13.0250318201 | 23.57 | 24.975 | 17.26 | 258844 | 20.49726714 | CS |
12 | -1 | -4.6511627907 | 21.5 | 29.35 | 17.26 | 311076 | 23.16653379 | CS |
26 | -1 | -4.6511627907 | 21.5 | 29.35 | 17.26 | 311076 | 23.16653379 | CS |
52 | -1 | -4.6511627907 | 21.5 | 29.35 | 17.26 | 311076 | 23.16653379 | CS |
156 | -1 | -4.6511627907 | 21.5 | 29.35 | 17.26 | 311076 | 23.16653379 | CS |
260 | -1 | -4.6511627907 | 21.5 | 29.35 | 17.26 | 311076 | 23.16653379 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions